Citadel Advisors’s Autolus Therapeutics AUTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.29M Buy
1,004,378
+815,470
+432% +$1.86M ﹤0.01% 2570
2025
Q1
$293K Sell
188,908
-135,094
-42% -$209K ﹤0.01% 4517
2024
Q4
$761K Buy
324,002
+20,994
+7% +$49.3K ﹤0.01% 3535
2024
Q3
$1.1M Sell
303,008
-222,780
-42% -$809K ﹤0.01% 3027
2024
Q2
$1.83M Sell
525,788
-160,692
-23% -$559K ﹤0.01% 2521
2024
Q1
$4.38M Buy
686,480
+646,715
+1,626% +$4.13M ﹤0.01% 1852
2023
Q4
$256K Buy
+39,765
New +$256K ﹤0.01% 4384
2023
Q3
Sell
-185,815
Closed -$442K 5861
2023
Q2
$442K Sell
185,815
-1,379,531
-88% -$3.28M ﹤0.01% 3753
2023
Q1
$2.88M Sell
1,565,346
-211,753
-12% -$390K ﹤0.01% 2222
2022
Q4
$3.38M Buy
1,777,099
+634,494
+56% +$1.21M ﹤0.01% 2140
2022
Q3
$2.45M Sell
1,142,605
-1,011,052
-47% -$2.16M ﹤0.01% 2540
2022
Q2
$6.1M Sell
2,153,657
-1,358,856
-39% -$3.85M ﹤0.01% 1681
2022
Q1
$14.6M Buy
3,512,513
+1,814,570
+107% +$7.57M ﹤0.01% 1133
2021
Q4
$8.81M Sell
1,697,943
-704,891
-29% -$3.66M ﹤0.01% 1565
2021
Q3
$15.7M Sell
2,402,834
-359,920
-13% -$2.36M ﹤0.01% 1081
2021
Q2
$18.3M Buy
2,762,754
+2,721,085
+6,530% +$18.1M ﹤0.01% 1011
2021
Q1
$239K Buy
41,669
+22,661
+119% +$130K ﹤0.01% 5253
2020
Q4
$170K Buy
19,008
+5,640
+42% +$50.4K ﹤0.01% 4554
2020
Q3
$156K Sell
13,368
-565,976
-98% -$6.6M ﹤0.01% 4154
2020
Q2
$9.29M Sell
579,344
-2,360
-0.4% -$37.8K ﹤0.01% 1133
2020
Q1
$3.49M Buy
581,704
+570,163
+4,940% +$3.42M ﹤0.01% 1736
2019
Q4
$152K Buy
+11,541
New +$152K ﹤0.01% 4204
2019
Q3
Sell
-71,285
Closed -$1.15M 4656
2019
Q2
$1.15M Buy
+71,285
New +$1.15M ﹤0.01% 2871